OpenEvidence An Official AI Partner of The New England Journal of Medicine OpenEvidence content includes figures, tables, multimedia and full-text clinical findings from The New England Journal of Medicine
About | OpenEvidence An Official AI Partner of The New England Journal of Medicine OpenEvidence content includes figures, tables, multimedia and full-text clinical findings from The New England Journal of Medicine
OpenEvidence AI becomes the first AI in history to score above 90% on . . . OpenEvidence AI, the large language model-based artificial intelligence powering the automatic ingestion, analysis, synthesis, and research on openevidence com, has reached a new milestone as the first AI to score over 90% on the United States Medical Licensing Examination (USMLE)
National Organization for Rare Disorders and OpenEvidence Partner to . . . Together, NORD and OpenEvidence will help build and scale a growing library of rare disease summaries in both clinician-focused and patient-friendly formats, combining AI-powered synthesis of the biomedical literature with expert review from specialists recommended by NORD, including experts from the NORD® Rare Disease Centers of Excellence Network The collaboration is designed to make high
OpenEvidence Creates the First AI in History to Score a Perfect 100% on . . . OpenEvidence, a medical search platform that currently provides evidence-based clinical decision and practice support for over 40% of physicians in the United States, was the first to develop an AI system to score over 90% on the USMLE
Announcements - OpenEvidence Sutter Health Collaborates with OpenEvidence to Bring Evidence-Based, AI-Powered Insights into Physician Workflows February 11, 2026
OpenEvidence Launches “Visits” : Real-Time Medical Intelligence for the . . . Visits can serve as your personal digital Clinical Assistant, integrating real-time medical intelligence directly into your notes Throughout each visit, OpenEvidence enriches your assessment and plan by automatically surfacing the latest clinical evidence and guidelines directly within your documentation workflow
OpenEvidence The leading medical information platform
OpenEvidence, the Fastest-Growing Application for Physicians in History . . . OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3 5 Billion ValuationOpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians
OpenEvidence to Become a Mayo Clinic Platform Accelerate Company OpenEvidence, an AI company pursuing foundational work in aligning Large Language Models (LLMs) to the medical domain, announced today it is to become a Mayo Clinic Platform Accelerate company As part of Mayo Clinic Platform Accelerate, OpenEvidence will collaborate with Mayo Clinic Platform to improve how health care information is structured and discovered